Adenosine phosphate photoaffinity probe as well as preparation method and application thereof

By adding bipropidine and alkyne-based photoaffinity probes to adenosine monophosphate (ATP), the problems of insufficient stability and specificity of existing probes are solved, enabling efficient and comprehensive labeling and identification of ATP-binding proteins.

CN121991149APending Publication Date: 2026-05-08SHANDONG UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202610127804.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-01-29
Publication Date
2026-05-08

AI Technical Summary

Technical Problem

Existing ATP-binding protein probes suffer from poor stability and insufficient specificity in identifying labeling sites, making it difficult to fully understand the binding pocket information of ATP-binding proteins.

Method used

The design incorporates a small photoaffinity group, bisacrylidine, and an alkyne group capable of bioorthogonal reactions at the phosphate site of adenosine monophosphate (ATP). Covalent labeling is achieved using ultraviolet light irradiation, and acidic cleavage linkages are used to improve probe stability and labeling efficiency.

Benefits of technology

It improves the labeling accuracy and efficiency of phosphate-binding proteins, enables comprehensive acquisition of binding pocket information, solves the problem of existing probes in identifying labeling sites, and provides a more comprehensive research tool for phosphate-binding proteins.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN121991149A_ABST
    Figure CN121991149A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of biological detection and analysis, and particularly relates to an adenosine phosphate photoaffinity probe as well as a preparation method and application thereof. The probe comprises an AMP-N (adenosine monophosphate-N) photoaffinity probe, an ADP-N (adenosine monophosphate-N) photoaffinity probe and an ATP-N (adenosine monophosphate-N) photoaffinity probe, the phosphoric acid part of adenosine monophosphate is modified with a photoaffinity group diaziridine with a small volume and alkynyl capable of carrying out a biological orthogonal reaction, and a connecting bond capable of cracking under an acidic condition is designed between adenosine monophosphate and a photoreactive group. The probe is high in stability and good in marking efficiency, can specifically mark the adenosine phosphate binding protein and identify the binding site of the adenosine phosphate binding protein, is suitable for screening, functional research and affinity analysis of the adenosine phosphate binding protein and discovery and verification of related drug targets, and has a wide application prospect.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the field of biodetection and analysis technology, specifically relating to a phosphate adenosine photoaffinity probe, its preparation method, and its application. Background Technology

[0002] The information disclosed in this background section is intended only to enhance understanding of the overall background of the invention and is not necessarily to be construed as an admission or in any way implying that such information constitutes prior art known to those skilled in the art.

[0003] Adenosine monophosphate (AMP), adenosine diphosphate (ADP), and adenosine triphosphate (ATP) play crucial roles in various biological processes, including energy metabolism, signal transduction, biosynthesis, and post-translational modification of proteins. ATP, as the cell's "energy currency," hydrolyzes into ADP and inorganic phosphate (Pi), driving numerous biosynthetic pathways and cellular activities, such as muscle contraction, nerve impulse transmission, substance transport, and biosynthesis. Furthermore, ATP acts as a signaling molecule in cell communication; extracellular ATP can activate purine receptors on the cell surface, triggering intracellular signaling cascades that regulate cell growth, differentiation, apoptosis, and immune responses. ADP also has important physiological functions in vivo. It is both a precursor and a hydrolysis product of ATP, and their interconversion constitutes the core of the cellular energy cycle. Changes in ADP concentration are key signals for cells to sense their energy status. High concentrations of ADP can activate metabolic pathways such as glycolysis and oxidative phosphorylation, promoting ATP regeneration. AMP is also a core molecule in energy metabolism, participating in energy storage and transfer, signal transduction, and metabolic regulation. The ratio of ATP to AMP concentrations in cells is usually maintained at about 100:1, and changes in this ratio can reflect dynamic changes in the cell's energy state.

[0004] The biological functions of adenosine monophosphate (ATP) are primarily realized through interactions with its binding proteins. ATP-binding proteins encompass various classes, including kinases, ATPases, molecular chaperones, transport proteins, structural proteins, and motility proteins. These proteins play crucial roles in signal transduction, DNA replication and repair, protein synthesis and folding, intracellular transport, and cell motility. Dysregulation of ATP-binding proteins can lead to a variety of diseases, including cancer, cardiovascular disease, metabolic disorders, and neurological disorders, making them important drug targets. ATP-binding proteins can also bind ADP, although the affinity may differ compared to ATP. While AMP-binding proteins also have important biological functions, research on them is less extensive than that on ATP-binding proteins. Systematic studies of these ATP-binding proteins will help elucidate their regulatory mechanisms, analyze the mechanisms of action of related drugs, and advance the development of new therapies.

[0005] Chemical proteomics methods employ probe-based labeling and enrichment techniques combined with high-resolution liquid chromatography-mass spectrometry (LC-MS) analysis, enabling systematic analysis of ATP-binding proteins on a proteomic scale. Previously reported ATP acyl phosphate probes can transfer biotin or dethiobiotin groups to lysine residues near the ATP-binding pocket, thereby achieving the enrichment and analysis of labeled proteins. These probes have shown good efficiency in identifying ATP-binding sites and have been widely used in kinase-related analyses; however, their labeling is limited to lysine residues, and the probes exhibit poor stability. To improve probe stability and labeling efficiency, the applicant previously developed an ATP-O photoaffinity probe. This probe contains a photoreactive group, bisacrylidine, on the γ-phosphate of ATP, allowing for covalent labeling of ATP-binding proteins under UV irradiation. It also contains a bioorthogonal alkyne group, enabling the enrichment or fluorescence analysis of the labeled protein. This probe has been successfully applied to the efficient analysis of ATP-binding proteins and can be used for target identification of kinase inhibitors. However, the significant protein modification in this method hinders the identification of the probe labeling site. Summary of the Invention

[0006] To address the shortcomings of existing technologies, this invention provides a phosphoadenosine (ATP) photoaffinity probe, its preparation method, and its applications. Specifically, this invention provides a novel ATP-N photoaffinity probe. By designing a linker between ATP and a photoreactive group that can cleave under acidic conditions, the quality of modification on the labeled peptide can be reduced after cleavage, facilitating the identification of labeling sites based on LC-MS / MS. Simultaneously, considering that many ATP-binding proteins also interact with ADP, a similar ADP-N photoaffinity probe was also prepared for global comparison of protein binding affinity to ATP and ADP. Since AMP-binding proteins differ somewhat from ATP or ADP-binding proteins, an AMP-N photoaffinity probe was also constructed for comparison with the previous two probes. These probes exhibit partially similar but distinct labeling patterns for different types of proteins, indicating that they have different potential application areas. This type of probe can efficiently label its binding proteins from cell lysates and can be used to identify the ATP binding sites of these proteins, contributing to in-depth research on the biological functions of ATP and its binding proteins, and providing important analytical tools for related drug target research and the discovery of new targets. Based on the above research results, this invention is thus completed.

[0007] Specifically, the present invention relates to the following technical solutions:

[0008] In a first aspect, the present invention provides a phosphate adenosine photoaffinity probe having the following structure:

[0009] This invention designs a photoaffinity probe by adding a small photoaffinity group, bisacrylidine, and an alkyne group capable of bioorthogonal reactions to the phosphate group of adenosine monophosphate (ATP). This type of probe offers several advantages. First, since the phosphate group of ATP is typically located outside the protein-binding pocket, modifications to the phosphate group have minimal impact on probe-protein binding. Second, unlike traditional probes that link biotin and acyl groups to the phosphate group, this probe utilizes UV irradiation to induce the generation of an active carbene intermediate, achieving covalent labeling of the bound protein while maintaining both reactivity and stability. Furthermore, this probe can label a variety of different amino acids, no longer limited to specific amino acids, thus providing more comprehensive information about the ATP-binding pocket.

[0010] A second aspect of the present invention provides a method for preparing the above-mentioned photoaffinity probe, the method comprising the following synthetic route:

[0011] A third aspect of the present invention provides a kit comprising at least the above-described photoaffinity probe.

[0012] A fourth aspect of the present invention provides the application of the above-described photoaffinity probes or kits in studies related to adenosine monophosphate binding proteins.

[0013] The phosphate-binding proteins include ATP-binding proteins, ADP-binding proteins, and AMP-binding proteins.

[0014] The beneficial technical effects of one or more of the above technical solutions: The phosphate-binding protein photoaffinity probe designed in the above technical solution is modified at the phosphate site of phosphate-binding protein, which has little impact on the binding of the probe to the protein. Moreover, the introduced diazinon-propidium photoaffinity group has high stability and can efficiently covalently label the bound protein under ultraviolet irradiation. The labeling is not limited by specific amino acids and can obtain more comprehensive binding pocket information. In particular, the acidic cleavage linkage designed in the photoaffinity probe can reduce the modification quality of the labeled peptide before mass spectrometry analysis, effectively solving the problem that the labeling site is difficult to identify due to the large modified group of existing probes, thus improving the accuracy and efficiency of binding site identification.

[0015] The aforementioned technical solutions provide three photoaffinity probes—AMP-N, ADP-N, and ATP-N—capable of specifically labeling different adenosine monophosphate (ATP)-binding proteins and globally comparing the binding affinity of proteins to different ATPs, thus providing an effective tool for the study of ATP-binding proteins. Furthermore, the preparation process of these photoaffinity probes is simple, with good purification results, stable product purity and yield, and a wide range of applications. These probes can be used for screening, labeling, enrichment, binding site identification, affinity analysis, discovery of new binding proteins, and drug target research of ATP-binding proteins, providing important technical support for the study of ATP-related biological mechanisms and drug development, and possessing significant practical application value. Attached Figure Description

[0016] The accompanying drawings, which form part of this invention, are used to provide a further understanding of the invention. The illustrative embodiments of the invention and their descriptions are used to explain the invention and do not constitute an improper limitation of the invention.

[0017] Figure 1 The effects of different labeling conditions on the labeling effect of adenosine monophosphate (ATP) probes in this invention are as follows: (a) Labeling results of cell lysates with different concentrations of ATP or ADP probes; (b) Labeling results of cell lysates with different concentrations of AMP probes; (c) Effect of ultraviolet irradiation on the labeling effect of ATP and ADP probes; (d) Effect of ultraviolet irradiation on the labeling effect of AMP probes.

[0018] Figure 2 The effects of different competing agents on the labeling effect of adenosine phosphate probes are as follows: (a) the effect of different competing agents on the labeling of ATP or ADP probes; (b) the effect of different competing agents on the labeling of AMP probes.

[0019] Figure 3 The following are examples of proteins and peptides labeled with ATP-N and ADP-N probes according to the present invention: (a) and (b) volcano plots showing the quantitative results of proteins or peptides labeled with 10 μM ATP-N probe with or without 100 μM ATP; (c) and (d) volcano plots showing the quantitative results of proteins or peptides labeled with 10 μM ADP-N probe with or without 100 μM ADP; (e) correlation analysis of proteins and peptides labeled with 10 μM ATP-N probe or ADP-N probe; and (f) GO molecular function analysis of proteins or peptides with an abundance ratio > 1.5 and a p-value < 0.05.

[0020] Figure 4Examples of secondary mass spectra of ATP-N probe-labeled peptides of the present invention: (a) Secondary mass spectrum of NAGK peptide containing ATP-N probe modification; (b) Secondary mass spectrum of VRK1 peptide containing ATP-N probe modification.

[0021] Figure 5 Examples of secondary mass spectra of ADP-N probe-labeled peptides of the present invention: (a) Secondary mass spectrum of DDX3X peptide containing ADP-N probe modification; (b) Secondary mass spectrum of DDX20 peptide containing ADP-N probe modification.

[0022] Figure 6 This invention provides a comparative analysis of proteins and peptides that are significantly competitive with ATP or ADP; (a) Venn diagrams comparing proteins that are significantly competitive with ATP or ADP (competition ratio > 1.5 and p < 0.05 in the competition experiment); (b) Volcano diagrams showing the quantitative results of the above proteins under 10 μM ATP-N or ADP-N probe labeling conditions; (c) Molecular functional analysis of proteins with ATP preference (ATP-N / ADP-N ratio > 1.5 and p < 0.05) or ADP preference (ATP-N / ADP-N ratio < 0.667 and p < 0.05); (d) Venn diagrams comparing peptides that are significantly competitive with ATP or ADP; (e) Volcano diagrams showing the quantitative results of the above peptides under 10 μM ATP-N or ADP-N probe labeling conditions; (f) ATP or ADP probe preference motif analysis.

[0023] Figure 7 Mass spectrometry analysis of proteins and peptides labeled with ATP-N and AMP-N probes according to the present invention; (a) and (b) volcano plots showing the quantitative results of proteins or peptides labeled with 50 μM AMP-N probe with or without 500 μM AMP; (c) Venn plot comparing proteins or labeled peptides with a ratio >1.5 and p <0.05 in the competition experiment; (d) Venn plot comparing proteins labeled with 50 μM AMP-N probe and 10 μM ATP-N probe; (e) GO molecular function analysis of 1118 proteins labeled only with 50 μM AMP-N probe; (f) GO molecular function analysis of 254 proteins labeled only with 10 μM ATP-N probe.

[0024] Figure 8This invention provides an analysis of the binding affinity of DDX family proteins to ATP or ADP. (a) A heatmap showing the quantitative analysis results of the identified DDX family proteins; (b) In-gel fluorescence imaging analysis of His-DDX3X and His-DDX20 labeled with 10 μM ATP-N or ADP-N probes in the presence of increasing concentrations of ATP or ADP; (c) and (d) Quantitative results of the fluorescence intensity of DDX3X and DDX20 protein bands. The fluorescence intensity of the competition group was normalized based on the band labeled with the probe without the competing agent. The fluorescence intensity of all bands was normalized using the intensity of Coomassie brilliant blue staining; (e) The KD value obtained from the ITC experiment and the simulated IC obtained based on the calculation results of (c) and (d). 50 The values ​​are compared.

[0025] Figure 9 The present invention uses ITC to determine the binding capacity of MAP2K6 with AMP, ADP or ATP; (a) ITC results of titrating 60 μM MAP2K6 with 2 mM AMP; (b) ITC results of titrating 104 μM MAP2K6 with 1.69 mM ADP; (c) ITC results of titrating 100 μM MAP2K6 with 1 mM ATP.

[0026] Figure 10 This invention relates to the effects of different concentrations of AMP, ADP, and GMP on the activity of MA2PK6 kinase.

[0027] Figure 11 The ATP-N probe of this invention 1 H NMR spectrum.

[0028] Figure 12 The ATP-N probe of this invention 13 C10 NMR spectrum.

[0029] Figure 13 The ATP-N probe of this invention 31 P NMR spectrum.

[0030] Figure 14 The ATP-N-CP probe of this invention 1 H NMR spectrum.

[0031] Figure 15 The ATP-N-CP probe of this invention 13 C10 NMR spectrum.

[0032] Figure 16 The ATP-N-CP probe of this invention 31 P NMR spectrum.

[0033] Figure 17The ADP-N probe of this invention 1 H NMR spectrum.

[0034] Figure 18 The ADP-N probe of this invention 13 C10 NMR spectrum.

[0035] Figure 19 The ADP-N probe of this invention 31 P NMR spectrum.

[0036] Figure 20 The ADP-N-CP probe of this invention 1 H NMR spectrum.

[0037] Figure 21 The ADP-N-CP probe of this invention 13 C10 NMR spectrum.

[0038] Figure 22 The ADP-N-CP probe of this invention 31 P NMR spectrum.

[0039] Figure 23 For the AMP-N probe of this invention 1 H NMR spectrum.

[0040] Figure 24 For the AMP-N probe of this invention 13 C10 NMR spectrum.

[0041] Figure 25 For the AMP-N probe of this invention 31 P NMR spectrum.

[0042] Figure 26 The AMP-N-CP probe of this invention 1 H NMR spectrum.

[0043] Figure 27 The AMP-N-CP probe of this invention 13 C10 NMR spectrum.

[0044] Figure 28 The AMP-N-CP probe of this invention 31 P NMR spectrum. Detailed Implementation

[0045] It should be noted that the following detailed descriptions are illustrative and intended to provide further explanation of this application. Unless otherwise specified, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this application pertains.

[0046] It should be noted that the terminology used herein is for the purpose of describing particular embodiments only and is not intended to limit the exemplary embodiments according to this application. As used herein, the singular form is intended to include the plural form as well, unless the context clearly indicates otherwise. Furthermore, it should be understood that when the terms "comprising" and / or "including" are used in this specification, they indicate the presence of features, steps, operations, devices, components, and / or combinations thereof. Experimental methods in the following detailed embodiments, unless specific conditions are specified, generally follow conventional methods and conditions within the art, which are fully explained in the literature.

[0047] The present invention will be further illustrated with specific examples. These examples are for illustrative purposes only and do not limit the scope of the invention. Unless otherwise specified, experimental conditions not explicitly stated in the examples are generally performed under conventional conditions or as recommended by the selling company. Materials and reagents used in the examples, unless otherwise specified, are commercially available.

[0048] Specifically, in a typical embodiment of the present invention, a phosphate photoaffinity probe is provided, the photoaffinity probe having the following structure:

[0049] This invention designs a photoaffinity probe by adding a small photoaffinity group, bisacrylidine, and an alkyne group capable of bioorthogonal reactions to the phosphate group of adenosine monophosphate (ATP). This type of probe offers several advantages. First, since the phosphate group of ATP is typically located outside the protein-binding pocket, modifications to the phosphate group have minimal impact on probe-protein binding. Second, unlike traditional probes that link biotin and acyl groups to the phosphate group, this probe utilizes UV irradiation to induce the generation of an active carbene intermediate, achieving covalent labeling of the bound protein while maintaining both reactivity and stability. Furthermore, this probe can label a variety of different amino acids, no longer limited to specific amino acids, thus providing more comprehensive information about the ATP-binding pocket.

[0050] In another specific embodiment of the present invention, a method for preparing the above-mentioned photoaffinity probe is provided, the method comprising the following synthetic route:

[0051] In another specific embodiment of the present invention, a kit is provided, the kit comprising at least the above-described photoaffinity probe. The kit may also comprise any other buffer solutions, reaction reagents, etc., which are not specifically limited herein.

[0052] In another specific embodiment of the present invention, the application of the above-mentioned photoaffinity probe or kit in the study of phosphate-binding proteins is provided.

[0053] The applications include at least the following: (a) Labeling and / or fluorescent gel imaging analysis of adenosine monophosphate-binding protein; (b) Identification of the binding site of adenosine monophosphate (ATP)-binding protein; (c) Affinity analysis of phosphate-binding proteins to phosphate nucleosides; (d) Analysis of new phosphate-binding proteins and related drug targets.

[0054] In (a)-(d), the cell containing the adenosine monophosphate binding protein is a prokaryotic cell or a eukaryotic cell. The prokaryotic cell can be a bacterial cell, and the eukaryotic cell can be a fungal cell, a plant cell, or an animal cell. The animal cell is further a mammalian cell, and even further a HEK293T cell.

[0055] The phosphate-binding proteins include ATP-binding proteins, ADP-binding proteins, and AMP-binding proteins.

[0056] The following examples further illustrate the present invention, but do not constitute a limitation thereof. It should be understood that these examples are for illustrative purposes only and are not intended to limit the scope of the invention.

[0057] Example 1: Design and Synthesis of Novel Adenosine Phosphophosphate Photoaffinity Probes 1.1 Experimental Reagents Methanol and acetonitrile (Oceanpak), dimethylformamide (Adamas), dimethyl sulfoxide (Sigma-aldrich), triethylamine (Greagent), hydrochloric acid, glacial acetic acid and sodium hydroxide (Sinopharm), pyridine (Acmec), disodium ATP and 3-(3-yne-1-butyl)-3-(2-iodoethyl)-3H-bisacrylidine (Bide Pharmaceuticals), disodium ADP and disodium AMP (Maclean), 6-iodo-1-hexyne (Aladdin), AQ-C18 column (Yuexu Technology).

[0058] 1.2 Experimental Apparatus Thermostatic magnetic stirrer (IKA), electric drying oven (Zhongyi Guoke), vortex mixer (IKA), balance, pH meter (Sartorius), CHEETAH Pro purification system, HPLC (Agela), mass spectrometer (Thermo Fisher Scientific), three-in-one UV analyzer, freeze dryer (Beijing Sihuan Freeze Drying), UV-Vis spectrophotometer (Shimadzu UV-2600).

[0059] 1.3 Experimental Procedure 1.3.1 Probe Synthesis and Purification

[0060] Synthesis of AMP-N photoaffinity probe (AMP-NP) and AMP control probe (AMP-N-CP): Weigh 0.0782 g (0.2 mmol, 1 eq) of disodium adenosine monophosphate into a 10 mL round-bottom flask, add 2 mL of water and stir to dissolve. Weigh 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide (EDC) (1 mmol, 0.1917 g, 5 eq) into a glass vial, add 2 mL of water, vortex to dissolve, and then add to the above aqueous solution. Stir at room temperature on a magnetic stirrer for 5 minutes. Weigh 3-aminoethyl-3-(but-3-ynyl)bisacrylidine (compound 1, 0.11 mmol, 14 μL, 1.1 eq) or 6-amino-1-hexyne (compound 2, 0.22 mmol, 0.022 g, 1.1 eq) into a glass vial, add 4 mL of dimethylformamide (DMF), vortex to dissolve, and then add to the reaction solution. Stir at room temperature for 5 hours. Extracted three times with dichloromethane to remove impurities from the organic phase, the upper aqueous phase was retained, and then lyophilized at -80°C. The lyophilized crude product was dissolved in 1 mL of water and purified using a WelFalsh AQ-C18 column (Regular 20-40 μm, 24 g) on ​​a CHEETAH Pro purification system. Mobile phase A was 50 mM triethylamine acetate solution (pH=8), and mobile phase B was 50 mM triethylamine acetate solution containing 30% acetonitrile (pH=8). The flow rate was 8 mL / min, and the detection wavelength was 254 nm. The gradient elution conditions were: 0–8 min, 5% B; 9–14 min, 10% B; 15–25 min, 20% B; 26–36 min, 40% B; 37–47 min, 60% B; 48–58 min, 80% B; 59–69 min, 100% B. Fractions containing the AMP-N photoaffinity probe or control probe were combined, lyophilized, dissolved in a small amount of water, and further purified using a C18 column (Yuexu Ultimate AQ-C18, 5 μm, 10 × 250 mm). Mobile phase A was water, mobile phase B was 30% acetonitrile, the flow rate was 2 mL / min, and the detection wavelength was 254 nm. Gradient elution conditions were: 0–5 min, 5% B; 6–10 min, 10% B; 11–20 min, 20% B; 21–40 min, 40% B; 41–55 min, 60% B; 56–65 min, 80% B; 66–76 min, 100% B. The product elutes at approximately 35% B. The fractions containing the probe are combined and lyophilized to obtain a white solid. The yields of the AMP-N photoaffinity probe and the control probe are 12% and 16%, respectively. The structure and purity are determined by high-resolution mass spectrometry, nuclear magnetic resonance, and liquid chromatography. The probe concentration is determined by the UV absorbance of its aqueous solution at 254 nm (extinction coefficient ε = 15400 M). -1 cm -1After the probe is dissolved, it is aliquoted and frozen at -80℃.

[0061] AMP control probe (AMP-N-CP): 1 H NMR (600 MHz, D2O) δ 8.81 (s, 1H), 8.55 (s, 1H), 6.42 (d, J = 5.9 Hz, 1H), 5.17 (t, 1H), 4.83 (s, 1H), 4.67 (s, 1H), 4.31 (d, J =6.4 Hz, 2H), 3.50 (q, J = 7.4 Hz, 5H, from NEt3H + ), 2.92 (t, J = 10.2 Hz, 2H),2.50 (s, 1H), 2.29-2.22 (m, 2H), 1.68-1.63 (m, 2H), 1.58 (t, J = 4.8 Hz, 8H, from NEt3H + ), 1.54 (m, 2H). 13 C NMR (151 MHz, D2O) δ 155.70, 152.85, 149.61,140.58, 119.19, 87.60, 86.39, 84.63 (d, J = 9.1 Hz), 74.40, 71.00, 69.42, 64.21(d, J = 5.0 Hz), 47.23 (from NEt3H + ), 41.29, 30.59 (d, J = 7.0 Hz), 25.59, 17.60 (d, J = 4.7 Hz), 8.71 (from NEt3H + ). 31 P NMR (162 MHz, D2O) δ 9.10. HRMS (m / z)calculated for C 16 H 24 N6O6P [MH] - : 425.1417; found 425.1310. AMP-N photoaffinity probe (AMP-NP): 1H NMR(400 MHz, D2O) δ 8.37 (s, 1H), 8.10 (s,1H), 5.97 (d, J = 5.6 Hz, 1H), 4.37 (d, J = 4 Hz, 1H), 4.25-4.13 (m, 1H), 3.84(d, J = 2.9 Hz, 2H), 3.04 (q, J = 7.3 Hz, 27H, from NEt3H + ), 2.09 (t, J = 2.6 Hz, 1H), 1.66 (td, J = 7.2, 2.8 Hz, 2H), 1.66 (td, J = 7.3, 2.7 Hz, 2H), 1.29-1.19(m, 4H), 1.12 (t, J = 7.3 Hz, 41H, from NEt3H + ). 13 C NMR(151 MHz, D2O) δ 155.44,152.63, 149.25, 140.08, 118.81, 87.10, 84.71, 83.53, 73.90, 70.53, 69.68,63.80 (d, J = 5.1 Hz), 46.74 (from NEt3H + ), 35.96, 33.92 (d, J = 7.1 Hz), 31.02,27.57, 12.38, 8.27 (from NEt3H + ). 31 P NMR (162 MHz, D2O) δ 8.48. HRMS (m / z)calculated for C 17 H 24 N8O6P [MH] - : 465.1405; found 465.1366. Synthesis of ADP-N photoaffinity probe (ADP-NP) and ADP control probe (ADP-N-CP): Except for replacing the disodium adenosine monophosphate with disodium adenosine diphosphate hydrate (0.2 mmol, 0.094 g), the rest of the synthesis and purification steps were consistent with those of the AMP-NP probe. The product elutes at approximately 32% B. The probe-containing fractions were combined and lyophilized to obtain a white solid. The yields of the ADP-N photoaffinity probe and the control probe were 15% and 16%, respectively. The structure and purity were determined by high-resolution mass spectrometry, nuclear magnetic resonance, and liquid chromatography. The probe concentration was determined by the UV absorbance of its aqueous solution at 254 nm (extinction coefficient ε = 15400 M). -1 cm -1 After the probe is dissolved, it is aliquoted and frozen at -80℃.

[0062] ADP control probe (ADP-N-CP): 1 H NMR (400 MHz, D2O) δ 8.47 (s, 1H), 8.16 (s, 1H), 6.05 (d, J = 5.7 Hz, 1H), 4.70 (t, J = 5.4 Hz, 1H), 4.46 (dd, J = 5.1, 3.8 Hz, 1H), 4.31 (dd, J = 3.8, 2.4 Hz, 1H), 4.13 (dt, J = 5.1, 2.4 Hz, 2H), 2.72-2.66 (m,2H), 2.16 (t, J = 2.6 Hz, 1H), 1.97 (td, J = 7.1, 2.7 Hz, 2H), 1.41-1.29 (m, 2H), 1.28-1.22 (m, 2H). 13 C NMR (151 MHz, D2O) δ 154.38, 151.55, 148.21, 139.28,117.76, 86.20, 85.18, 83.10 (d, J = 9.4 Hz), 73.41, 69.48, 68.24, 64.08, 40.37,29.27 (d, J = 8.8 Hz), 24.39, 16.45. 31 P NMR (162 MHz, D2O) δ -1.30 (d, J = 22.1 Hz, 1P), -11.32 (d, J= 22.0 Hz, 1P).HRMS (ESI) m / z calcd. for C 16 H 24 N6O9P2[MH] - :505.1007, found: 505.0969. ADP-N photoaffinity probe (ADP-NP): 1 H NMR (400 MHz, D2O) δ 8.50 (s, 1H), 8.18 (s,1H), 6.08 (d, J = 5.1 Hz, 1H), 4.74-4.70 (m, 1H), 4.50-4.43 (m, 1H), 4.33 (s,1H), 4.15 (s, 2H), 2.67-2.52 (m, 2H), 2.25 (t, J = 2.6 Hz, 1H), 1.83 (d, J = 7.3Hz, 2H), 1.49-1.42 (m, 4H). 13 C NMR (101 MHz, D2O) δ 155.13, 152.28, 148.93,139.95, 118.50, 86.99, 84.18, 83.73 (d, J = 8.1 Hz), 74.19, 70.14, 69.64,64.76, 36.32, 33.91 (d, J = 7.0 Hz), 30.92, 27.61, 12.37. 31 P NMR (162 MHz, D2O) δ -2.02 (d, J = 21.9 Hz, 1P), -11.34 (d, J = 22.3 Hz, 1P).HRMS (ESI) m / z calcd. forC 17 H 24 N8O9P2[MH] - : 545.1069, found: 545.1028. Synthesis of ATP-N photoaffinity probe (ATP-NP) and ATP control probe (ATP-N-CP): Except for replacing the disodium adenosine monophosphate with the disodium adenosine triphosphate hydrate (0.2 mmol, 0.11 g), the rest of the synthesis and purification steps were consistent with those of the AMP-NP probe. The product elutes at approximately 30% B. The probe-containing fractions were combined and lyophilized to obtain a white solid. The yields of the ATP-N photosynthetic probe and the control probe were 10% and 12%, respectively. The structure and purity were determined by high-resolution mass spectrometry, nuclear magnetic resonance, and liquid chromatography. The probe concentration was determined by the UV absorbance of its aqueous solution at 254 nm (extinction coefficient ε = 15400 M). -1 cm -1 After the probe is dissolved, it is aliquoted and frozen at -80℃.

[0063] ATP control probe (ATP-N-CP): 1 H NMR (400 MHz, D2O) δ 8.56 (s, 1H), 8.27 (s, 1H), 6.15 (d, J = 6.0 Hz, 1H), 4.78 (s, 1H), 4.57 (dd, J = 5.1, 3.4 Hz, 1H), 4.40 (p, J = 2.9 Hz, 1H), 4.31- 4.19 (m, 2H), 2.86-2.77 (m, 2H), 2.24 (t, J = 2.6 Hz, 1H), 2.08 (td, J = 6.9, 2.7 Hz, 2H), 1.48-1.31 (m, 4H). 13 C NMR (101 MHz, D2O) δ 155.70,152.92, 149.19, 139.87, 118.68, 86.70, 86.07, 84.03 (d, J = 9.3 Hz), 74.36,70.39, 68.90, 65.14 (d, J = 5.6 Hz), 41.11, 30.09 (d, J = 8.9 Hz), 25.14, 17.26. 31 P NMR (162 MHz, D2O) δ -1.39 (d, J = 20.5 Hz, 1P), -11.65 (d, J = 19.5 Hz, 1P), -23.11 (t, J= 20.2 Hz, 1P). HRMS (ESI) m / z calcd. for C 16 H 25 N6O 12 P3[M - H] - : 585.0671, found: 585.0628. ATP - N photoaffinity probe (ATP - N - P): 1 1H NMR(400 MHz, D2O) δ 8. 63 (s, 1H), 8.35 (s,1H), 6.21 (d, J = 5.9 Hz, 1H), 4.85 (s, 1H), 4.62 (dd, J = 5.1, 3.5 Hz, 1H), 4.46(p, J = 3.0 Hz, 1H), 4.31 - 4.20 (m, 2H), 2.75 (m, 2H), 2.38 (t, J = 2.6 Hz, 1H),1.99 (td, J = 7.3, 2.6 Hz, 2H), 1.63 (t, J = 7.3 Hz, 2H), 1.57 (t, J = 7.3 Hz, 2H). 13 13C NMR(101 MHz, D2O) δ 155.60, 152.88, 149.07, 139.83, 118.62, 86.84, 84.39,83.93(d, J = 8.1 Hz), 74.36, 70.31, 69.68, 65.13 (d, J = 5.4 Hz), 36.32, 33.93(d, J = 7.4 Hz), 31.01, 27.79, 12.41. 31 31P NMR(162 MHz, D2O) δ -1.89 (d, J = 21.0 Hz,1P), -11.59 (d, J = 19.9 Hz, 1P), -23.06 (t, J = 20.2 Hz, 1P). HRMS (ESI) m / z calcd. for C 17 H 25N8O 12 P3[MH] - : 625.0732, found: 625.0691. Example 2: Adenosine monophosphate (ATP) photoaffinity probes for protein labeling and fluorescence gel imaging analysis in cell lysates. To verify whether the novel phosphate-adenosine photoaffinity probe can effectively label its binding protein, the labeling of several probes was first compared by fluorescence gel imaging experiments, and the specificity of the probe labeling its binding protein was verified by competition experiments with ATP, ADP or AMP.

[0064] 2. Materials and Methods 2.1 Experimental Reagents Methanol (Fuyu), Glacial Acetic Acid (Fuyu), Triethanolamine (Tianjin Fuyu), Sodium Chloride (Titan), Chloroform (Tieta), Sodium Bicarbonate (Bide Pharmaceuticals), Rhodamine B-PEG3-Azide, Tri-(2-Carboxyethyl)phosphohydrochloride (Bide Pharmaceuticals), Copper Sulfate (Sigma), Tris[(1-Benzyl-1H-1,2,3-Triazol-4-yl)methyl]amine, Bromophenol Blue (Aladdin) β β-Mercaptoethanol (Beyotime Pharmaceuticals), 4-hydroxyethylpiperazine ethanesulfonic acid (Beyotime), ethylenediaminetetraacetic acid (Solepro), sodium dodecyl sulfate (Genview), Triton X-100 (Beyotime), magnesium chloride (Maclean), tetramethylethylenediamine (Titan), 30% acrylamide (Dingguo), Coomassie Brilliant Blue R-250 (Beyotime Pharmaceuticals), tris(hydroxymethyl)aminomethane hydrochloride, phosphatase inhibitor A, phosphatase inhibitor B, protease inhibitor (Aimer), Bradford kit (Beyotime), BCA kit (Beyotime), fetal bovine serum (FBS, ExCellBio), penicillin-streptomycin (PS, Gibco), high glucose DMEM (Gibco), AMP, ADP and ATP and their corresponding probes.

[0065] 2.2 Experimental Apparatus Pipettes, centrifuges (Eppendorf), thermostatic metal baths (Thermo Fisher Scientific), microplate readers, electrophoresis apparatus (Bio-Rayet), 365 nm UV lamps (ZF-1), vortex mixers (Aika), horizontal shakers (Dalon), pH meters (Sartorius), NanoDrop one (Thermo Fisher Scientific), fluorescence imagers (Amersham Imager 800, GE), multispectral laser imagers (Amersham Typhoon 5, Siterfan), and incubators (Thermo Fisher Scientific).

[0066] 2.3 Experimental Procedure Fluorescent gel imaging of HEK 293T cell lysates labeled with an adenosine phosphate probe. Take an appropriate amount of HEK 293T cells, thaw them on ice, and then lyse them on ice for 30 minutes using 5-10 times the volume of 1% Triton X-100 lysis buffer (1% Triton X-100, 50 mM 4-hydroxyethylpiperazine ethanesulfonic acid, 150 mM sodium chloride, pH = 7.4, with phosphatase inhibitor A, phosphatase inhibitor B, and protease inhibitor added before use), vortexing for 5 seconds every 10 minutes. Centrifuge at 4°C for 30 minutes at 8000 rpm. Collect the supernatant and treat with NAP-5 to remove endogenous nucleotide molecules. Determine the protein concentration using the Bradford method. Take 100 μg of protein from each sample, dilute it with 0.1% Triton X-100 lysis buffer, add 1 mM magnesium chloride, different concentrations of probes, and competitors to the specified concentration, and make the final volume of the system 100 μL, with a final protein concentration of 1 μg / μL. After incubation on ice, the mixture was irradiated with a 365 nm UV lamp. Then, rhodamine B-PEG3-azide was linked via click chemistry by sequentially adding tri-(2-carboxyethyl)phosphohydrochloride, a dimethyl sulfoxide solution of tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine, copper sulfate, and a dimethyl sulfoxide solution of rhodamine B-PEG3-azide to final concentrations of 1 mM, 0.1 mM, 1 mM, and 0.1 mM, respectively. After vortexing at room temperature for 2 hours, the protein was precipitated overnight with ten volumes of ice-cold methanol, or by using four volumes of methanol, one volume of chloroform, and three volumes of water. The mixture was centrifuged at 4°C for 10 minutes at 8000 rpm. Discard the supernatant. Wash the protein precipitate twice with ice-cold methanol, then dissolve it in 30 μL of 4% sodium dodecyl sulfate buffer (4% sodium dodecyl sulfate, 150 mM sodium chloride, 50 mM triethanolamine, pH = 7.4). Protein concentration was determined using the BCA method. Add 4× loading buffer (0.25 M tris(hydroxymethyl)aminomethane, pH = 6.8, 4% sodium dodecyl sulfate, 40% glycerol, 0.02% bromophenol blue; add 200 μL β-mercaptoethanol per 800 μL before use), heat at 95°C for 5 minutes, and perform polyacrylamide gel electrophoresis (4% stacking gel, 10% separating gel) at a constant voltage of 90 V for approximately 110 minutes. After electrophoresis, cut off the separating gel and perform fluorescent gel imaging using an Amersham Imager 800 with an excitation source of 535 nm. After fluorescence analysis, the sample was stained with Coomassie Brilliant Blue staining solution (0.1% Coomassie Brilliant Blue, 10% glacial acetic acid, 50% methanol) for 30 minutes, and then the background color was removed with destaining solution (10% glacial acetic acid, 30% methanol).

[0067] 2.4 Results and Discussion 2.4.1 Comparison of probe markings Comparison of fluorescent gel imaging results with different probe labels revealed that the labeling signal of the protein bands gradually increased with increasing probe concentration. The labeling intensity and bands of ATP-NP and ADP-NP were quite similar, and both were effective at labeling proteins in cell lysates at a concentration of 10 μM. Figure 1 a). In contrast, AMP-NP has lower labeling efficiency, requiring a concentration increase to 50 μM to achieve effective labeling ( Figure 1 b). Furthermore, under conditions without UV irradiation, the probe labeling was weak and similar to the control probe, indicating that the labeling of phosphoadenosine photoaffinity probes depends on photoreactive groups and UV irradiation (b). Figure 1 c, 1d).

[0068] 2.4.2 Competition Experiment for Probe Labeling To verify the specificity of probe labeling, the three probes were competitively labeled using ATP, ADP, or AMP, respectively. The results showed that for ATP or ADP probes, the fluorescence intensity of the protein bands significantly decreased after the addition of ATP or ADP; however, no competitive effect was observed after the addition of AMP. Figure 2 a) The labeling results are consistent with those of the first two probes. In the AMP probe competition experiment, the addition of ATP, ADP, AMP, or GMP all weakened the probe labeling to varying degrees. Figure 2 (b) This result indicates that, in addition to recognizing AMP-binding proteins, AMP probes may also label some ATP or ADP-binding proteins, possibly because some AMP-binding proteins can also bind to ATP or ADP.

[0069] Example 3: Proteomic analysis of cell lysates recorded by a phosphate photoaffinity probe Under the above-mentioned probe labeling conditions, HEK 293T cell lysates were labeled with adenosine monophosphate (ATP) photoaffinity probes and protein profile samples were prepared. High-resolution liquid chromatography-mass spectrometry (LC-MS) was used for analysis. Based on the competitive effect of ATP on probe-labeled proteins, the specificity of the probe in labeling its binding proteins was verified.

[0070] 3.1 Experimental Reagents Copper sulfate, ammonium bicarbonate, iodoacetamide (Bide Pharmaceuticals), Triton X-100 (Beyotime), magnesium chloride (Maclean), methanol, triethanolamine, glacial acetic acid (Tianjin Fuyu), chloroform (Tieta), formic acid, acetonitrile (Thermo Fisher Scientific), sodium dodecyl sulfate, tri-(2-carboxyethyl)phosphohydrochloride, 4-hydroxyethylpiperazine ethanesulfonic acid, urea (Jieweier), biotin-PEG3-azide, biotin-DADPS-azide (Leyan), trypsin, streptavidin beads (Thermo Fisher Scientific), phosphatase inhibitor A, phosphatase inhibitor B, protease inhibitor (Aimer), Bradford kit, BCA kit (Beyotime), 10× phosphate buffer (Solepro).

[0071] 3.2 Experimental Apparatus Centrifuge (Eppendorf), centrifugal concentrator (GE), NAP-5 (GE), 365 nm UV lamp, constant temperature metal bath (mini H100), ultrasonic cleaner (Shandong Boke), ELISA reader (Bio-Rayet), vortex analyzer (IKA), horizontal shaker (Dalong), pH meter (Sartorius), rotary shaker, C18 column, Vanquish Neo HPLC, Orbitrap Exploris 480 mass spectrometer (Thermo Fisher Scientific).

[0072] 3.3 Experimental Procedure 3.3.1 Preparation of probe-labeled HEK 293T cell lysate mass spectrometry samples by on-Beads enzymatic digestion method HEK 293T cell lysates containing 2 mg of protein were labeled with 10 μM ATP or ADP probes, or cell lysates containing 1 mg of protein were labeled with 50 μM AMP probes. The labeling procedure was the same as for the fluorescent gel imaging experiment, except that Rhodamine B-PEG3-azide was replaced with biotin-DADPS-azide. After clicking the chemical reaction and protein precipitation, the protein precipitate was dissolved in 100 μL of 4% sodium dodecyl sulfate buffer, and then 900 μL of dilution buffer (150 mM sodium chloride, 50 mM 4-hydroxyethylpiperazine ethanesulfonic acid, pH = 7.4) was added. Separately, 50 μL of streptavidin beads were taken per sample, washed three times with 20-fold volume dilution buffer before use, and then added to the sample. The microbeads were bound on a rotating shaker at room temperature for 2 hours. Non-specifically bound proteins were then washed away using a centrifugal filter column. The microbeads were washed with 1× phosphate solution (pH = 7.4), 10× phosphate solution (pH = 7.4), 1× phosphate solution (pH = 7.4), water, and 50 mM ammonium bicarbonate solution containing 8 M urea, using 1 mL of each solution for five consecutive washes. Finally, the microbeads were transferred using 50 mM ammonium bicarbonate solution containing 8 M urea and resuspended in 500 μL of this solution. Tris-(2-carboxyethyl)phosphohydrochloride solution was added to a final concentration of 20 mM, and the reaction was carried out at 37°C for 1 hour. Then, iodoacetamide solution was added to a final concentration of 50 mM, and the reaction was carried out at room temperature in the dark for 30 minutes. Centrifuge at 3000 rpm for 2 minutes, gently aspirate and discard the supernatant, resuspend the microbeads in 25 mM ammonium bicarbonate solution, centrifuge again and discard the supernatant. Repeat this process three times. Resuspend the microbeads in 100 μL of 25 mM ammonium bicarbonate solution, add 1 μL of trypsin (1 μg / μL), and incubate at 37℃ for 16 hours. Transfer the supernatant to a new centrifuge tube, then add 200 μL of 25 mM ammonium bicarbonate solution to each sample to resuspend the microbeads. Combine the supernatants in the new centrifuge tubes. Repeat this process 5 times to obtain sample ① (which does not contain probe-modified free peptides). The remaining microbeads were resuspended in 200 μL of 10% formic acid, mixed on a rotary shaker at room temperature for 30 minutes, and then centrifuged at 3000 rpm for 2 min. The supernatant was transferred to a new centrifuge tube, and this process was repeated three times. The combined supernatants were incubated at 37°C for 30 minutes. 200 μL of 50% acetonitrile was added to the remaining microbeads and incubated at 37°C for 30 minutes. The supernatant was transferred and washed once with 200 μL of 50% acetonitrile. The combined supernatants yielded sample ②. The peptide solution was concentrated by centrifugation, desalted using a C18 column, and stored at -80°C until LC-MS / MS detection. All samples were dissolved in 20 μL of pure water. Sample ① was injected at a volume of 4 μL, and sample ② at a volume of 8 μL.

[0073] 3.3.2 LC-MS / MS detection method and data analysis Samples were analyzed using an Orbitrap Exploris 480 mass spectrometer equipped with a nanospray ionization source, coupled with a Vanquish Neo ultra-high performance liquid chromatography system. A self-prepared C18 capillary column with an inner diameter of 75 μm and a length of 18 cm was used. The analytical column packing material was Reprosil-Pur120 C18-AQ (Mike, Germany), with a particle size of 3 μm. Mobile phase A was a 98% aqueous solution containing 0.1% formic acid, and mobile phase B was a 98% acetonitrile solution containing 0.1% formic acid. The flow rate was set to 300 nL / min, with the following elution gradient: 0–5 min, 5% B; 130 min, 26% B; 140 min, 36% B; 141 min, 72% B; 151–166 min, 80% B. The spray voltage was 1.9 kV, and the ion transfer tube temperature was 320 °C. Full-scan mass spectrometry was performed using an Orbitrap mass analyzer at a resolution of 120,000 m / z in the range of 350–1500 m / z. The normalized AGC target was 300%, and the maximum injection time was 25 ms. Data-dependent acquisition (DDA) mode was used, with an MS scan cycle time of 3 seconds and a data acquisition time of 0–151 minutes. Ions with a charge ≥2 in the full-scan mass spectrometry were fragmented in an HCD collision chamber (normalized collision energy 30%), and tandem mass spectrometry was performed using an Orbitrap mass analyzer at a resolution of 15,000 m / z. The normalized AGC target for the secondary mass spectrometry was 50%, and the maximum injection time was automatically selected.

[0074] The acquired MS raw files were analyzed using Proteome Discoverer 2.5 software, and a database search was performed using the Uniprot Human Proteome Database (November 2022, total 20,401 proteins). Enzyme specificity was set to trypsin. Cysteine ​​aminomethylation was set as a fixed modification, while methionine oxidation and N-terminal acetylation were set as variable modifications. To identify probe modification sites, probe modifications (+252.1950 Da) were added as variable modifications to the amino acids C / D / E / H / K / R / S / T / Y that showed a labeling preference for diazinon.

[0075] 3.4 Results and Discussion 3.4.1 Mass spectrometry analysis of proteins labeled with ATP-N and ADP-N photoaffinity probes Mass spectrometry analysis using 10 μM ATP-N probe labeling identified over 3000 proteins in three biological replicates, of which 924 proteins were identified with probe-labeled sites. The ADP-N probe, however, identified 760 proteins with probe-modified sites. Both probes showed similar labeling efficiencies, but the ATP-N probe was slightly superior to the ADP-N probe in identifying labeled peptides. To better screen for proteins that specifically bind to ATP or ADP, 100 μM ATP or ADP was added as a competitive agent before probe labeling, and the results were compared with samples without a competitive agent. Unlabeled quantitative analysis revealed that most proteins or proteins with significantly reduced abundance of labeled peptides in the ATP or ADP competitive agent groups were previously reported ATP-binding proteins. Figure 3 Although the abundance of proteins labeled by the two probes was similar, the abundance of the labeled peptides differed significantly. Figure 3 e). GO molecular function analysis was performed on proteins or peptides with an abundance ratio greater than 1.5 and a p-value less than 0.05 between the probe-labeled group and the competing group. The results showed that ATP-N had a slightly better enrichment effect on kinases, while ATP-binding proteins with helicase activity were only enriched by ADP-N probe labeling. Figure 3 f).

[0076] Further analysis of the probe modification sites revealed that most of the amino acid residues labeled by the probe were located in the ATP-binding pocket of the protein. For example, in the ATP probe-labeled sample, peptide modification of N-acetylglucosamine kinase (NAGK) was detected, with the probe labeled on the 16th glutamic acid residue near its ATP-binding pocket. Figure 4 a). Another example is a nuclear chromatin kinase, VRK1, which is overexpressed in many types of tumors and associated with poor prognosis. Based on reported crystal structures, it was found that the probe was labeled with glutamate at position 73 near the ATP-binding pocket of VRK1 (a). Figure 4 b). In ADP-labeled samples, multiple DEAD-box (DDX) RNA helicases were significantly enriched, and for most of the detected DDX family proteins, peptides labeled on the DEAD motif were identified, located near the nucleotide-binding pocket of the DDX. Figure 5 (ab). The above examples illustrate that the probes developed in this study can not only be used to analyze proteins enriched by the probes, but also to determine the modification sites of the probes on the proteins. These modification sites are usually located near the ATP or ADP binding pockets of the proteins, providing a powerful tool for the functional study of ATP-binding proteins and the target analysis of related drugs.

[0077] To analyze the specificity of ATP-N and ADP-N probe-labeled proteins and peptides, proteins and peptides whose labeling was significantly inhibited by the competitive agent in the competitive assay were compared. A total of 41 proteins were identified. Figure 6 a) and 10 peptides ( Figure 6 Labeling with d) can be significantly inhibited by both ATP and ADP. Among these, most proteins or peptides competitively inhibited by ATP showed stronger labeling signals than those with ADP-N probes in ATP-N probe labeling experiments. Figure 6 b), proteins or peptides that are competitively inhibited by ADP show stronger signals when labeled with ADP-N probes. Figure 6 This indicates that probe labeling efficiency is highly correlated with the binding affinity of the target protein to ATP or ADP. Molecular functional analysis showed that kinases were significantly enriched in proteins that preferred ATP-N probe labeling, while helicases were more enriched in ADP-N probe labeling. Figure 6 c). Motif analysis of the labeled peptides revealed that the GxGxxG and HRDxK motifs located in the ATP-binding pocket of the kinase were more readily labeled by the ATP-N probe, while the ADP-N probe tended to label the KxxDFG motif in the kinase. This may be due to the different relative distances between the photoreactive group and the specific labeled residue. Figure 6 f). In addition, the ADP-N probe can also label the DEAD motif in helicases well, which is consistent with its better enrichment results for helicases.

[0078] The above results indicate that both ATP-N and ADP-N probes have good labeling effects and selectivity for ATP-binding proteins, and can efficiently identify the phosphate-adenosine binding sites of these proteins, providing a powerful tool for functional studies of ATP-binding proteins and target analysis of related drugs. The labeling results of the two probes show both similarities and differences, suggesting that the two probes may have different application potentials.

[0079] 3.4.2 Mass spectrometry results analysis of proteins labeled with AMP-N photoaffinity probes Protein labeling was performed using a 50 μM AMP-N probe, and combined with mass spectrometry analysis, more than 4000 proteins were identified in three biological replicates, of which 1788 were identified with probe-labeled sites. To screen for proteins that specifically bind to AMP, 500 μM AMP was added as a competitive agent before probe labeling, and the samples were compared with those without a competitive agent. Label-free quantitative analysis revealed that the abundance of 7 proteins was significantly decreased in the competitive group (odds ratio > 1.5, p < 0.05), namely DNPH1, LATS1, GLUD1, CUTA, MAP2K6, MAP2K3, and MAP2K1 (…). Figure 7a). DNPH1 is a known AMP-binding protein, and existing literature reports that increasing AMP concentration inhibits DNPH1 activity. At the peptide level, a total of 23 peptides in the competitive group met the screening criteria (ratio > 1.5, p < 0.05), involving three MAP2K family kinases: MAP2K6, MAP2K4, and MAP2K3. Figure 7 b). The above results indicate that MAP2K family members can be significantly enriched by AMP probes, among which MAP2K6 and MAP2K3 meet the screening criteria at both the protein and modified peptide levels. Figure 7 c). Since MAP2K6 is more significant in terms of both ratio and p-value, further investigations will be conducted to explore the interaction between AMP and the MAP2K6 protein, verify its binding ability, and assess the potential impact of AMP on MAP2K6 kinase activity.

[0080] Based on the fluorescent gel electrophoresis results, the bands labeled with ATP-N and ADP-N probes were quite similar, while the bands labeled with AMP-N probes showed significant differences from the former two. A comparative analysis of the mass spectrometry samples labeled with AMP-N and ATP-N was performed. The results showed that there was partial overlap between the proteins labeled with AMP-N and ATP-N probes. This overlap mainly included RNA-binding proteins and ATP-binding proteins, presumably because these proteins can bind to both AMP and ATP. Figure 7 d). Regarding the number of proteins identified, the 50 μM AMP-N probe labeled 1788 proteins with labeled sites, higher than the 10 μM ATP-N probe. This may be due to the higher concentration used and the superior chromatographic column used in the LC-MS analysis of this sample. Further direct parallel comparisons are needed to more accurately identify the differences between the two. GO molecular function analysis of the proteins specifically identified by the two probes revealed that among the 1118 proteins identified by the AMP-N probe alone, the main functions were concentrated in RNA binding, protein binding, and cadherin binding, while ATP-binding proteins were not significantly enriched. Figure 7 e). Among the 254 proteins identified solely by the ATP-N probe, ATP-binding proteins were significantly enriched, indicating that the ATP-N probe is better able to label and enrich ATP-binding proteins. Figure 7 f). In summary, AMP-N and ATP-N probes differ significantly in the range of proteins they identify, reflecting their different characteristics in binding preference and functional coverage, as well as their different application areas.

[0081] Example 4: Application Study of Adenosine Phosphate Photoaffinity Probe 4.1 Application of ATP-N and ADP-N photoaffinity probes in analyzing the affinity between proteins and phosphate nucleosides According to LC-MS / MS quantitative analysis, DEAD-box (DDX) RNA helicase showed significant enrichment under ADP-N probe labeling compared to the ATP-N probe. Specifically, the ADP-N probe showed significantly better labeling of DDX3X than the ATP-N probe, while the labeling of DDX20 showed little difference between the two probes. Figure 8 a), therefore, these two proteins were chosen to further investigate the reasons for the differences in the two probe labels. To verify the probe specificity, equal amounts of purified recombinant proteins His-DDX3X and His-DDX20 were mixed and labeled with ATP-N probe or ADP-N probe in the presence of increasing concentrations of ATP or ADP, respectively. Figure 8 b). Under the same conditions, the labeling intensity of the ADP-N probe for DDX3X was much higher than that of the ATP-N probe, while the labeling response of DDX20 to the two probes was similar, which is consistent with the results of LC-MS quantitative analysis. The ADP-N probe inhibition effect of ADP on DDX3X was significantly stronger than that on DDX20, and significantly stronger than the inhibition effect of ATP on ATP-N probe labeling. Figure 8 c). For DDX20, there was no significant difference in competitive inhibition between ATP and ADP ( Figure 8 d). The binding affinity of these two proteins to ATP or ADP was further determined by isothermal titration calorimetry (ITC). Consistent with the results of the labeling experiment, DDX3X bound to ADP more strongly than to ATP, and was also significantly stronger than DDX20 bound to ADP. The IC50 values ​​were calculated based on the fitted curves. 50 The value of K obtained from the ITC experiment D The values ​​show a high degree of agreement in DDX3X, while the values ​​in DDX20 show a significant deviation, possibly due to large fluctuations in the experimental data. Figure 8 e). These results all indicate that this probe labeling method can be applied to affinity studies of ATP or ADP-binding proteins.

[0082] 4.2 Application of AMP-N photoaffinity probes in the discovery of novel AMP-binding proteins Based on the aforementioned AMP-N photoaffinity probe LC-MS / MS quantitative analysis results, MAP2K family members showed significant enrichment at both the overall protein level and the modified peptide level, with MAP2K6 showing significant enrichment in both the protein-to-modified peptide ratio and p-value. The MAP2K family, or mitogen-activated protein kinase kinases, is a key central component of the MAPK signaling pathway, specifically phosphorylating downstream MAPKs (such as ERK, JNK, and p38), thereby initiating signaling cascades and regulating different MAPK pathways. MAP2K6, as a key kinase in the MAPK signaling pathway, depends on ATP binding and Mg²⁺. +Synergistically, it specifically catalyzes the diphosphorylation of downstream MAPK14 (p38α) at ​​Thr180 and Tyr182 sites. Activated MAPK14 can further phosphorylate downstream transcription factors and kinases, thereby participating in gene expression and cellular function regulation. To further explore the interaction between AMP and MAP2K6, the binding affinity of AMP, ADP, and ATP to MAP2K6 was first assessed using isothermal titration calorimetry (ITC). Figure 9 The results showed that AMP could bind to MAP2K6, but its binding strength was lower than that of ATP and ADP. Further analysis indicated that ATP and ADP each have only one binding site with MAP2K6, while AMP may have two binding sites, suggesting that AMP may interact with MAP2K6 through a different binding mode than ATP and ADP, thereby potentially affecting the activity of this kinase.

[0083] To investigate the effect of AMP on MAP2K6 kinase activity, Flag-MAP2K6 was overexpressed and purified in HEK 293T cells, and its substrate GST-MAPK14 was expressed and purified in *E. coli*. The phosphorylation level of MAPK14 was measured to assess MAP2K6 activity. The results showed that in the presence of ATP without the addition of Flag-MAP2K6, GST-MAPK14 exhibited only slight autophosphorylation; however, no phosphorylation of MAPK14 was observed when both Flag-MAP2K6 and GST-MAPK14 were added without ATP, indicating that MAP2K6-catalyzed substrate phosphorylation is ATP-dependent. In the reaction with 1 mM AMP without ATP, GST-MAPK14 could not undergo phosphorylation, demonstrating that AMP cannot replace ATP in the kinase response. The effects of different concentrations of AMP and other nucleotides (ADP, GMP) on MAP2K6 activity were further compared. The results showed that AMP inhibited MAPK14 phosphorylation to varying degrees across the concentration range of 0.01–10 mM, with 10 mM AMP significantly reducing MAP2K6 activity. However, 10 mM ADP and GMP also weakened phosphorylation levels, with the inhibitory strength in the following order: ADP > AMP > GMP. Figure 10 The above results indicate that although AMP can inhibit MAP2K6 activity in vitro, its inhibitory efficacy is weaker than that of ADP, and the intracellular AMP concentration is low. Therefore, whether AMP regulates MAP2K6 activity under physiological conditions requires further investigation.

[0084] The above description is merely a preferred embodiment of the present invention and is not intended to limit the invention. Various modifications and variations can be made to the present invention by those skilled in the art. Any modifications, equivalent substitutions, improvements, etc., made within the spirit and principles of the present invention should be included within the scope of protection of the present invention.

Claims

1. A phosphate-adenosine photoaffinity probe, characterized in that, The photoaffinity probe has the following structure: 。 2. The method for preparing the photoaffinity probe according to claim 1, characterized in that, The preparation method includes the following synthetic route: 。 3. A reagent kit, characterized in that, The kit contains at least the phosphate photoaffinity probe as described in claim 1.

4. The kit according to claim 3, characterized in that, The kit also includes buffer solution and reaction reagents.

5. The use of the phosphoadenosine photoaffinity probe of claim 1 or the kit of any one of claims 3-4 in the study of phosphoadenosine-binding proteins.

6. The application as described in claim 5, characterized in that, The applications include phosphate-binding protein labeling and / or fluorescent gel imaging analysis.

7. The application as described in claim 5, characterized in that, The application includes the identification of phosphate-binding protein binding sites.

8. The application as described in claim 5, characterized in that, The applications include the analysis of affinity between phosphate-binding proteins and phosphate nucleosides.

9. The application as described in claim 5, characterized in that, The applications include the analysis of novel phosphate-binding proteins and related drug targets.

10. The application as described in claims 5-9, characterized in that, The cell containing the adenosine monophosphate binding protein is a prokaryotic cell or a eukaryotic cell. The prokaryotic cell is a bacterial cell, and the eukaryotic cell is a fungal cell, a plant cell, or an animal cell. The animal cell is further a mammalian cell, and even further a HEK293T cell. The phosphate-binding proteins include ATP-binding proteins, ADP-binding proteins, and AMP-binding proteins.